NCT02386813
- Conditions
- Extranodal NK/T-cell Lymphoma, Nasal Type, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
- Samsung Medical Center Seoul, South Korea
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
2,774 public trials
698 recruiting studies
Lymphoma, Non-Hodgkin trial results
Completed
Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies
NCT00446342
- Conditions
- B-Lymphoid Malignancies, Blood Protein Disorders, Cardiovascular Diseases, +29 more
- Locations
-
- City of Hope Duarte, California, United States
- Stanford Cancer Center Stanford, California, United States
- Winship Cancer Institute at Emory University Atlanta, Georgia, United States
- Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
NCT01004991
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Weill Cornell Medical College New York, United States
NCT01120834
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Weill Cornell Medical College New York, United States
NCT00097929
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
Not specified
Completed
Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)
NCT00091559
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
Not specified
NCT02278510
- Conditions
- Glioma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Completed
Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon
NCT03087929
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Sunnybrook Health Sciences Centre, Odette Cancer Centre Toronto, Ontario, Canada
NCT00329602
- Conditions
- Dyssomnias, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- GSK Investigational Site Camperdown, New South Wales, Australia
- GSK Investigational Site Kippa-Ring, Queensland, Australia
- GSK Investigational Site Woodville, South Australia, Australia
- GSK Investigational Site Clayton, Victoria, Australia
Completed
A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas
NCT02788916
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Santiago de Compostela, A Coruna, Spain
- Barcelona, Spain
- Santander, Cantabria, Spain
- Córdoba, Cordoba, Spain